{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T13:03:09Z","timestamp":1789218189853,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s10620-019-05905-y","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T14:33:52Z","timestamp":1571841232000},"page":"1784-1789","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Tumor Necrosis Factor Inhibitors May Have Limited Efficacy for Complex Perianal Fistulas Without Luminal Crohn\u2019s Disease"],"prefix":"10.1007","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0658-3062","authenticated-orcid":false,"given":"Jeffrey D.","family":"McCurdy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Parlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Dawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Samji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glara Gaeun","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilianna","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blair","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Sabri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"key":"5905_CR1","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1007\/s10350-007-9006-5","volume":"50","author":"MS Kasparek","year":"2007","unstructured":"Kasparek MS, Glatzle J, Temeltcheva T, et al. Long-term quality of life in patients with Crohn\u2019s disease and perianal fistulas: influence of fecal diversion. Dis Colon Rectum. 2007;50:2067\u20132074.","journal-title":"Dis Colon Rectum"},{"key":"5905_CR2","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/j.1365-2036.2009.04088.x","volume":"30","author":"SC Ng","year":"2009","unstructured":"Ng SC, Plamondon S, Gupta A, et al. Prospective assessment of the effect on quality of life of anti-tumour necrosis factor therapy for perineal Crohn\u2019s fistulas. Aliment Pharmacol Ther. 2009;30:757\u2013766.","journal-title":"Aliment Pharmacol Ther"},{"key":"5905_CR3","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1007\/s10620-013-2830-7","volume":"58","author":"M Chaparro","year":"2013","unstructured":"Chaparro M, Zanotti C, Burgueno P, et al. Health care costs of complex perianal fistula in Crohn\u2019s disease. Dig Dis Sci. 2013;58:3400\u20133406. \nhttps:\/\/doi.org\/10.1007\/s10620-013-2830-7\n\n.","journal-title":"Dig Dis Sci"},{"key":"5905_CR4","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1053\/gast.2002.32362","volume":"122","author":"DA Schwartz","year":"2002","unstructured":"Schwartz DA, Loftus EVJ, Tremaine WJ, et al. The natural history of fistulizing Crohn\u2019s disease in Olmsted County, Minnesota. Gastroenterology. 2002;122:875\u2013880.","journal-title":"Gastroenterology"},{"key":"5905_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1136\/gut.21.6.525","volume":"21","author":"G Hellers","year":"1980","unstructured":"Hellers G, Bergstrand O, Ewerth S, et al. Occurrence and outcome after primary treatment of anal fistulae in Crohn\u2019s disease. Gut. 1980;21:525\u2013527.","journal-title":"Gut"},{"key":"5905_CR6","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1097\/DCR.0000000000000733","volume":"59","author":"JD Vogel","year":"2016","unstructured":"Vogel JD, Johnson EK, Morris AM, et al. Clinical practice guideline for the management of anorectal abscess, fistula-in-ano, and rectovaginal fistula. Dis Colon Rectum. 2016;59:1117\u20131133.","journal-title":"Dis Colon Rectum"},{"key":"5905_CR7","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/DCR.0b013e31825228b0","volume":"55","author":"TW Eglinton","year":"2012","unstructured":"Eglinton TW, Barclay ML, Gearry RB, et al. The spectrum of perianal Crohn\u2019s disease in a population-based cohort. Dis Colon Rectum. 2012;55:773\u2013777.","journal-title":"Dis Colon Rectum"},{"key":"5905_CR8","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1136\/gutjnl-2013-306709","volume":"63","author":"KB Gecse","year":"2014","unstructured":"Gecse KB, Bemelman W, Kamm MA, et al. A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn\u2019s disease. Gut. 2014;63:1381\u20131392.","journal-title":"Gut"},{"key":"5905_CR9","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/BF02054434","volume":"39","author":"J Garcia-Aguilar","year":"1996","unstructured":"Garcia-Aguilar J, Belmonte C, Wong WD, et al. Anal fistula surgery. Factors associated with recurrence and incontinence. Dis Colon Rectum. 1996;39:723\u2013729.","journal-title":"Dis Colon Rectum"},{"key":"5905_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1067\/j.cpsurg.2017.02.003","volume":"54","author":"NN Mahmoud","year":"2017","unstructured":"Mahmoud NN, Halwani Y, de Montbrun S, et al. Current management of perianal Crohn\u2019s disease. Curr Probl Surg. 2017;54:262\u2013298.","journal-title":"Curr Probl Surg"},{"key":"5905_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1053\/j.gastro.2006.11.041","volume":"132","author":"JF Colombel","year":"2007","unstructured":"Colombel JF, Sandborn WJ, Rutgeerts P, et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn\u2019s disease: the CHARM trial. Gastroenterology. 2007;132:52\u201365.","journal-title":"Gastroenterology"},{"key":"5905_CR12","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1056\/NEJMoa030815","volume":"350","author":"BE Sands","year":"2004","unstructured":"Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn\u2019s disease. N Engl J Med. 2004;350:876\u2013885.","journal-title":"N Engl J Med"},{"key":"5905_CR13","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","volume":"340","author":"DH Present","year":"1999","unstructured":"Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn\u2019s disease. N Engl J Med. 1999;340:1398\u20131405.","journal-title":"N Engl J Med"},{"key":"5905_CR14","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/j.gastro.2003.08.025","volume":"125","author":"WJ Sandborn","year":"2003","unstructured":"Sandborn WJ, Fazio VW, Feagan BG, et al. AGA technical review on perianal Crohn\u2019s disease. Gastroenterology. 2003;125:1508\u20131530.","journal-title":"Gastroenterology"},{"key":"5905_CR15","doi-asserted-by":"publisher","first-page":"644\u201359","DOI":"10.1038\/ajg.2011.73","volume":"106","author":"AC Ford","year":"2011","unstructured":"Ford AC, Sandborn WJ, Khan KJ, et al. Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol. 2011;106:644\u201359. \nhttps:\/\/doi.org\/10.1038\/ajg.2011.73\n\n.","journal-title":"Am J Gastroenterol"},{"key":"5905_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00247-013-2771-5","volume":"44","author":"A Shenoy-Bhangle","year":"2014","unstructured":"Shenoy-Bhangle A, Nimkin K, Goldner D, et al. MRI predictors of treatment response for perianal fistulizing Crohn disease in children and young adults. Pediatr Radiol. 2014;44:23\u201329.","journal-title":"Pediatr Radiol"},{"key":"5905_CR17","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/ibd\/izy055","volume":"24","author":"C Brochard","year":"2018","unstructured":"Brochard C, Landemaine A, L\u2019Heritier AM, et al. Anal fistulas in severe perineal Crohn\u2019s disease: Mri assessment in the determination of long-term healing rates. Inflamm Bowel Dis. 2018;24:1612\u20131618.","journal-title":"Inflamm Bowel Dis"},{"key":"5905_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4253\/wjge.v4.i5.185","volume":"4","author":"SN Adler","year":"2012","unstructured":"Adler SN, Yoav M, Eitan S, et al. Does capsule endoscopy have an added value in patients with perianal disease and a negative work up for Crohn\u2019s disease? World J Gastrointest Endosc. 2012;4:185\u2013188.","journal-title":"World J Gastrointest Endosc"},{"key":"5905_CR19","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1177\/2050640619834464","volume":"7","author":"TW Stevens","year":"2019","unstructured":"Stevens TW, D\u2019Haens GR, Duijvestein M, et al. Diagnostic accuracy of faecal calprotectin in patients with active perianal fistulas. United European Gastroenterol J. 2019;7:496\u2013506.","journal-title":"United European Gastroenterol J"},{"key":"5905_CR20","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1007\/s00261-016-0989-z","volume":"42","author":"IS Oliveira","year":"2017","unstructured":"Oliveira IS, Kilcoyne A, Price MC, et al. MRI features of perianal fistulas: is there a difference between Crohn\u2019s and non-Crohn\u2019s patients? Abdom Radiol (NY). 2017;42:1162\u20131168.","journal-title":"Abdom Radiol (NY)"},{"key":"5905_CR21","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.crohns.2012.07.024","volume":"7","author":"AP Zbar","year":"2013","unstructured":"Zbar AP, Horesh N, Bucholtz V, et al. Are there specific endosonographic features in Crohn\u2019s patients with perianal fistulae? Journal of Crohn\u2019s and Colitis. 2013;7:490\u2013496.","journal-title":"Journal of Crohn\u2019s and Colitis"},{"key":"5905_CR22","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10151-011-0719-z","volume":"15","author":"J Blom","year":"2011","unstructured":"Blom J, Nystrom PO, Gunnarsson U, et al. Endoanal ultrasonography may distinguish Crohn\u201cs anal fistulae from cryptoglandular fistulae in patients with Crohn\u201ds disease: a cross-sectional study. Tech Coloproctol. 2011;15:327\u2013330.","journal-title":"Tech Coloproctol"},{"key":"5905_CR23","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s10151-016-1494-7","volume":"20","author":"RS van Onkelen","year":"2016","unstructured":"van Onkelen RS, Gosselink MP, van Meurs M, et al. Pro-inflammatory cytokines in cryptoglandular anal fistulas. Tech Coloproctol. 2016;20:619\u2013625.","journal-title":"Tech Coloproctol"},{"key":"5905_CR24","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1080\/00365520701320489","volume":"42","author":"K Kiehne","year":"2007","unstructured":"Kiehne K, Fincke A, Brunke G, et al. Antimicrobial peptides in chronic anal fistula epithelium. Scand J Gastroenterol. 2007;42:1063\u20131069.","journal-title":"Scand J Gastroenterol"},{"key":"5905_CR25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1445-2197.2010.05278.x","volume":"80","author":"G Owen","year":"2010","unstructured":"Owen G, Keshava A, Stewart P, et al. Plugs unplugged. Anal fistula plug: the Concord experience. ANZ J Surg. 2010;80:341\u2013343.","journal-title":"ANZ J Surg"},{"key":"5905_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00384-007-0398-4","volume":"23","author":"O Schwandner","year":"2008","unstructured":"Schwandner O, Stadler F, Dietl O, et al. Initial experience on efficacy in closure of cryptoglandular and Crohn\u2019s transsphincteric fistulas by the use of the anal fistula plug. Int J Colorectal Dis. 2008;23:319\u2013324.","journal-title":"Int J Colorectal Dis"},{"key":"5905_CR27","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1097\/SLA.0000000000000479","volume":"260","author":"DS Gingold","year":"2014","unstructured":"Gingold DS, Murrell ZA, Fleshner PR. A prospective evaluation of the ligation of the intersphincteric tract procedure for complex anal fistula in patients with Crohn\u2019s disease. Ann Surg. 2014;260:1057\u20131061.","journal-title":"Ann Surg"},{"key":"5905_CR28","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/DCR.0b013e3181ce8b01","volume":"53","author":"A Soltani","year":"2010","unstructured":"Soltani A, Kaiser AM. Endorectal advancement flap for cryptoglandular or Crohn\u2019s fistula-in-ano. Dis Colon Rectum. 2010;53:486\u2013495.","journal-title":"Dis Colon Rectum"},{"key":"5905_CR29","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1007\/s10350-004-7248-z","volume":"45","author":"N Mizrahi","year":"2002","unstructured":"Mizrahi N, Wexner SD, Zmora O, et al. Endorectal advancement flap: are there predictors of failure? Dis Colon Rectum. 2002;45:1616\u20131621.","journal-title":"Dis Colon Rectum"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05905-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-019-05905-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05905-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T23:18:57Z","timestamp":1603235937000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-019-05905-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["5905"],"URL":"https:\/\/doi.org\/10.1007\/s10620-019-05905-y","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,22]]},"assertion":[{"value":"11 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"JD and SM: Honoraria from Takeda, Jansen, Abbvie, and Ferring.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}